Cargando…
PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies
Nearly half of metastatic breast cancers (MBC) have genetic aberrations in the PI3K/AKT pathway. To investigate the distinct effect of these aberrations on MBC, 193 MBC patients who progressed after the early line (≤2) salvage treatment voluntarily received next generation sequencing (NGS) for a pan...
Autores principales: | Tang, Yu, Li, Jing, Xie, Ning, Yang, Xiaohong, Liu, Liping, Wu, Hui, Tian, Can, He, Ying, Wang, Xiao, He, Qiongzhi, Hu, Zhe-Yu, Ouyang, Quchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053638/ https://www.ncbi.nlm.nih.gov/pubmed/31980592 http://dx.doi.org/10.18632/aging.102701 |
Ejemplares similares
-
Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
por: Zhou, Dabo, et al.
Publicado: (2019) -
Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]
por: Zhou, Dabo, et al.
Publicado: (2021) -
Targeting p85β nuclear translocation for the tumors with PIK3CA helical domain mutations
por: He, Baoyu, et al.
Publicado: (2022) -
Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
por: Hu, Zhe-Yu, et al.
Publicado: (2018) -
Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer
por: Vatte, Chittibabu, et al.
Publicado: (2019)